EUVIMEDEUVIMED entdecken
Crossref

Size‐exclusion LC‐UV/HRMS based method for the analysis of aggregates in synthetic GLP‐1 analog liraglutide and evaluation of excipient impact on aggregation

Devendra Badgujar, Sanket Bawake, Ashwini Chawathe, Nitish Sharma iD

Biomedical Chromatography · 2024

DOI: 10.1002/bmc.5983 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2024. Verfasst von Devendra Badgujar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research-Ahmedabad (Ministry of Chemicals and Fertilizers, …. Hauptthemen laut MEDLINE: Liraglutide, Chromatography, Gel, Excipients, Mass Spectrometry. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Gefördert von: Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peptide aggregation is one of the key challenges associated with the development of therapeutic peptides. Peptide and protein aggregates are considered as one of the most important critical quality attributes (CQA). Therapeutic liraglutide (LGT) is proteinaceous in nature, and aggregation can be triggered by various environmental stress condition. Therefore, it is essential to separate and identify aggregation states of such drugs. In this study, we have established size exclusion chromatography‐liquid chromatography‐ultraviolet/high resolution mass spectrometry (SEC‐LC‐UV/HRMS) method to separate and identify the stress induced LGT aggregates. LGT samples were subjected to photolytic, thermal, freeze thaw and shaking stress conditions. Additionally, LGT solution was incubated with surfactant and excipient that are commonly used in peptide formulation, to evaluate their impact on aggregation level and physicochemical stability over time. The developed SEC method was also validated for specificity, accuracy, precision and linearity. The results of this study will be useful for investigators to monitor LGT aggregates during product development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiraglutideChromatography, GelExcipientsMass SpectrometryReproducibility of ResultsProtein AggregatesLinear ModelsDrug StabilityLimit of Detection

Stichwörter der Autor:innen

SEC‐HRMSaggregationliraglutidetherapeutic peptide

Substanzen

LiraglutideExcipientsProtein Aggregates

Autor:innen und Institutionen

  • Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research-Ahmedabad (Ministry of Chemicals and Fertilizers, Government of India), Opposite Air Force Station, Palaj, India.

ORCID-Profile: Nitish Sharma

Förderung

  • Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers
  • Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India

Zitieren

APA

Badgujar, D., Bawake, S., Chawathe, A., & Sharma, N. (2024). Size‐exclusion LC‐UV/HRMS based method for the analysis of aggregates in synthetic GLP‐1 analog liraglutide and evaluation of excipient impact on aggregation. Biomedical Chromatography. https://doi.org/10.1002/bmc.5983

Vancouver

Badgujar D, Bawake S, Chawathe A, Sharma N. Size‐exclusion LC‐UV/HRMS based method for the analysis of aggregates in synthetic GLP‐1 analog liraglutide and evaluation of excipient impact on aggregation. Biomedical Chromatography. 2024. doi:10.1002/bmc.5983

BibTeX
@article{Badgujar2024,
  author = {Badgujar, Devendra and Bawake, Sanket and Chawathe, Ashwini and Sharma, Nitish},
  title = {Size‐exclusion LC‐UV/HRMS based method for the analysis of aggregates in synthetic GLP‐1 analog liraglutide and evaluation of excipient impact on aggregation},
  journal = {Biomedical Chromatography},
  year = {2024},
  doi = {10.1002/bmc.5983}
}
Kostenlos starten →